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ertebrate oocytes arrest in metaphase of the
second meiotic division (MII), where they maintain
a high cdc2/cyclin B activity and a stable, bipolar
spindle because of cytostatic factor (CSF) activity. The Mos–
MAPK pathway is essential for establishing CSF. Indeed,
oocytes from the 
 
mos
 
 
 
/
 
 
 
 strain do not arrest in MII and
activate without fertilization, as do 
 
Xenopus
 
 
 
laevis 
 
oocytes
injected with morpholino oligonucleotides directed against
Mos. In 
 
Xenopus
 
 oocytes, p90Rsk (ribosomal S6 kinase), a
V
 
MAPK substrate, is the main mediator of CSF activity. We
show here that this is not the case in mouse oocytes. The
injection of constitutively active mutant forms of Rsk1 and
Rsk2 does not induce a cell cycle arrest in two-cell mouse
embryos. Moreover, these two mutant forms do not restore
MII arrest after their injection into 
 
mos
 
 
 
/
 
 
 
 oocytes. Even-
tually, oocytes from the triple Rsk (1, 2, 3) knockout present
a normal CSF arrest. We demonstrate that p90Rsk is not
involved in the MII arrest of mouse oocytes.
 
Introduction
 
Most oocytes from vertebrate species are naturally arrested in
metaphase of the second meiotic division (MII), and harbor a
stable spindle with sister chromatids aligned on the metaphase
plate. Fertilization triggers sister chromatid separation and the
extrusion of the second polar body, as well as entry into embry-
onic development. The activity that keeps oocytes arrested in
MII was first identified in 
 
Rana pipiens
 
 eggs and was called
cytostatic factor (CSF) by Masui and Markert (1971). This
activity, when injected into a two-cell 
 
Xenopus laevis 
 
embryo,
induces a cell cycle arrest in the M phase. The precise molecular
nature of CSF has not been characterized, but it has been un-
ambiguously shown in 
 
Xenopus 
 
and mouse oocytes that the
Mos–MAPK pathway is required for generating CSF activity.
Indeed, 
 
mos
 
 knockout oocytes, which do not activate MAPK
from the extracellular regulated kinase (ERK) 1/2 family, as
well as 
 
Xenopus
 
 oocytes injected with anti-Mos morpholino
oligonucleotides, activate parthenogenetically (Colledge et al.,
1994; Hashimoto et al., 1994; Verlhac et al., 1996; Dupre et al.,
2002). In 
 
Xenopus
 
 eggs, p90Rsk (ribosomal S6 kinase), a well-
known, in vivo MAPK substrate, has been involved in generating
CSF activity. There are two closely related p90Rsk that are
present and active in CSF-arrested 
 
Xenopus
 
 eggs: Rsk1 and
Rsk2; Rsk2 is the most abundant isoform (Bhatt and Ferrell,
2000). Constitutively active forms of p90Rsk (1 or 2) induce
CSF arrest after injection into a 
 
Xenopus
 
 embryo, and do so
independently of the activation of the Mos–MAPK pathway
(Bhatt and Ferrell, 1999; Gross et al., 1999). Despite the presence
of Rsk1, a Rsk2-depleted extract cannot undergo CSF arrest
in response to Mos (Bhatt and Ferrell, 1999). Eventually,
 
Xenopus
 
 oocytes treated with U0126, a MAPK/ERK kinase
(MEK) inhibitor, go to interphase after meiosis resumption.
Overexpression of constitutively active p90Rsk into U0126-
treated 
 
Xenopus
 
 oocytes rescues a normal MII arrest with a
stable, bipolar spindle (Gross et al., 2000). Studies from 
 
Xenopus
 
eggs, therefore, suggest that p90Rsk is the sole mediator of the
Mos–MAPK pathway involved in CSF activity (Bhatt and
Ferrell, 1999; Gross et al., 1999, 2000).
In mouse oocytes, p90Rsk was also shown to be down-
stream of the Mos–MAPK pathway (Kalab et al., 1996).
However, 
 
mos
 
 knockout oocytes that do not activate MAPK,
but still harbor 50% of the residual activity of p90Rsk, do not
develop CSF activity (Kalab et al., 1996). Also, two MAPK
substrates are necessary for maintaining spindle stability during
the CSF arrest in mouse oocytes: MISS (MAPK interacting and
spindle stabilizing) protein (Lefebvre et al., 2002) and DOC1R
(deleted in oral cancer one related; Terret et al., 2003a). The
requirement of these two substrates suggests that p90Rsk is
probably not a unique, downstream target of the Mos–MAPK
pathway during mouse oocyte meiotic maturation. For these
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reasons, we decided to determine whether p90Rsk was neces-
sary and sufficient to establish CSF arrest in mouse oocytes. In
this manuscript, we demonstrate that proteins of the p90Rsk
family are not involved in the MII arrest in mouse oocytes by
using both overexpression of constitutively active Rsk1 and 2
in mouse oocytes and embryos, and analyzing the CSF arrest in
oocytes from the Rsk (1, 2, 3) knockout strain.
 
Results and discussion
 
Injection of Mos or constitutively active MEK into one blas-
tomere of a late, two-cell mouse embryo induces a cell cycle
arrest and can be used as a test for CSF activity (Fig. 1; Verlhac
et al., 2000). We injected RNA-encoding, constitutively active
p90Rsk into one blastomere of a two-cell mouse embryo (Sil-
verman et al., 2004). Although we obtained a 98% block after
the injection of Mos, neither constitutively active Rsk1 nor
Rsk2 was able to induce a cell cycle arrest above the back-
ground level (Fig. 1, compare A–C with G). This was not
caused by a lack of overexpression of the mutant forms of Rsk,
because, for example, Rsk2wt and Rsk2ca were overexpressed
 
 
 
10 times, compared with endogenous Rsk (Fig. 1 H; the anti-
Rsk2 antibody recognizes both wild-type Rsk2 and endoge-
nous Rsk2, but does not recognize the constitutively active
Rsk2). The same extract probed with an anti-Flag antibody
shows that Rsk2ca overexpression was even higher than
Rsk2wt overexpression (Fig. 1 H, right). Furthermore, injec-
tion of the same RNA preparation that encodes Rsk1ca or
Rsk2ca into one blastomere of a two-cell 
 
Xenopus
 
 embryo in-
duces the expected cell cycle arrest in the injected blastomeres
(Fig. 1, compare F with D and E; Silverman et al., 2004). Rsk1
and Rsk2 are abundant in 
 
Xenopus
 
 oocytes and early embryos
(Silverman et al., 2004). Interestingly, the amount of expres-
sion of the exogenous proteins versus the amount of expression
of the endogenous proteins is even greater in the mouse than in
 
Xenopus
 
 (10 times more than the endogenous proteins in the
mouse embryo compared with 10 times less than the endoge-
nous proteins in 
 
Xenopus
 
; Silverman et al., 2004; unpublished
data). Thus, whereas Mos or active MEK is sufficient to induce
a cell cycle arrest in mouse embryos, constitutively active Rsk
is not.
Oocytes from the 
 
mos
 
 
 
/
 
 
 
 strain are not arrested in MII,
but activate spontaneously in the absence of fertilization and
extrude a second polar body. To determine whether p90Rsk
was able to restore MII arrest in these oocytes, we overex-
pressed constitutively active Rsk1 or 2. As expected, the injec-
tion of RNA-encoding Mos completely rescued the MII arrest
in this strain, and an oocyte did not extrude a second polar body
(see Fig. 3, B and D). Oocytes from the 
 
mos
 
 
 
/
 
 
 
 strain injected
with RNA-encoding Rsk1ca extruded their first and second po-
lar bodies with the same timing as control, noninjected oocytes
(Fig. 2 A). Oocytes from this particular experiment, however,
overexpressed Rsk1ca, as shown in Fig. 2 B. We observed the
same phenotype after an injection of RNA-encoding Rsk2ca
(Fig. 3, C and D). Therefore, the injection of RNA-encoding,
constitutively active Rsk1 or 2 does not restore MII arrest in
 
mos
 
 
 
/
 
 
 
 oocytes. The absence of rescue is not caused by a lack
of Rsk1ca or Rsk2ca expression (Fig. 2 B; and Fig. 3 E, bottom
lanes 2–4), nor is it caused by a lack of activity, because both
forms are recognized by an anti-phosphoRsk antibody that is
specific for active p90Rsk (Fig. 3 E, top lanes 2–4).
Our data suggested that p90Rsk is not sufficient to induce
CSF activity in mouse oocytes. There are four Rsk members in
the mouse: Rsk1–4. Though similar in structure to the other
Rsk family members, Rsk4 has a function that is distinct from
that of Rsk1–3. In the early mouse embryo, Rsk4 expression is
Figure 1. Constitutively active Rsk1 or 2 does not induce
CSF arrest in early mouse embryos, but does so in early
Xenopus embryos. (A–C) Phase-contrast image of mouse
embryos injected at the two-cell stage into one blastomere
and observed 24 h later. (A) Cleavage arrest induced
after Mos-RNA injection (black arrowheads). No arrest is
observed after the injection of RNA-encoding Rsk2wt or
Rsk2ca (B and C, respectively). Bar, 50  m. (D–F) Phase-
contrast image of two-cell Xenopus embryos injected into
one blastomere with RNA-encoding Mos (D), Rsk2wt (E),
and Rsk2ca (F). Embryos were observed 3 h after injection.
The black arrowheads point toward blastomeres, which
undergo cell cycle arrest after injection. Bar, 100  m.
(G) Percentage of cleavage arrest (%bloc) induced in one
blastomere of a late two-cell mouse embryo after an in-
jection of RNA-encoding Mos, Rsk1ca, Rsk2wt, and
Rsk2ca. The number in parentheses corresponds to the
number of embryos that were analyzed. Two-cell embryos
were injected between 48 and 50 h after a human
chorionic gonadotropin injection, which corresponds to
 4 h before the two- to four-cell division. Error bars are
the SD from three experiments. (H) Immunoblotting of 30
two-cell mouse embryos that were either noninjected (NI)
or injected with Rsk2wt or Rsk2ca RNA into one blasto-
mere and collected 24 h after injection. Left panel is
revealed with an anti-Rsk2 antibody. Right panel is revealed
with an anti-Flag antibody. The anti-Rsk2 recognizes
endogenous Rsk2, but not Rsk2ca. 
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inversely correlated to the presence of activated ERK1/2 (My-
ers et al., 2004). Moreover, in the early 
 
Xenopus
 
 embryo, Rsk4
has an inhibitory role in the transduction of MAPK signaling
pathways. This inhibitory role is dependent on a region that is
not conserved in Rsk1–3 (Myers et al., 2004). Because activa-
tion of the Mos–MAPK pathway is required for the CSF arrest,
we can rule out the possibility that Rsk4, a downstream inhibi-
tor of ERK1/2, is involved in mediating this activity. More-
over, we were able to amplify Rsk2 and Rsk4 mRNA from
whole ovaries using RT-PCR, but were not able to amplify
Rsk4 mRNA from mouse immature oocytes using RT-PCR.
However, Rsk2 mRNA was consistently amplified from these
oocytes using RT-PCR (unpublished data). This suggests, but
does not prove, that the Rsk4 mRNA is either absent or ex-
pressed at very low levels in mouse oocytes.
Therefore, in order to determine whether p90Rsk is nec-
essary for MII arrest in mouse oocytes, we checked if oocytes
from the recently produced Rsk (1, 2, 3) triple knockout (un-
published data) were able to arrest in MII. The lack of Rsk1–3
expression in these mice is shown in protein extracts from the
liver and from mitotic embryonic fibroblasts that were derived
from these deficient mice (Fig. 4 D, lanes 3 and 4).
As shown in Fig. 4, immature oocytes from the Rsk (1, 2,
3) knockout strain underwent meiosis resumption, as assessed
by germinal vesicle breakdown (GVBD). They extruded their
first polar body with a frequency similar to that of control oo-
cytes (97% extrusion of the first polar body compared with
80% in control oocytes). Furthermore, oocytes from this defi-
cient strain were arrested in MII with typical, barrel-shaped
spindles (Fig. 4 B). They segregated homologous chromo-
somes and harbored in MII sister chromatids aligned on the
metaphase plate, which is typical of a CSF arrest (Fig. 4 C).
Like control oocytes, oocytes from the Rsk (1, 2, 3)–deficient
strain remained arrested in MII and never extruded a second
polar body like oocytes from the c-
 
mos
 
 knockout strain did.
Our data demonstrate that p90Rsk is neither necessary nor
sufficient to establish a CSF arrest in mouse oocytes (Fig. 4 F).
This contradicts the work of Paronetto et al. (2004), which shows
that the injection of active Rsk2 protein, and not RNA, into one
blastomere of a two-cell embryo blocks the division of the in-
jected blastomere in 
 
 
 
30% of the cases. However, we assume
that this block is, in fact, a delay of the division because Paro-
netto et al. (2004) did not observe the embryos further than one
division of the control blastomere. This delay is likely a result of
the trauma caused by the injection of protein into the blastomere.
Our results show that the signaling pathway leading to
CSF arrest diverges at the level of p90Rsk between 
 
Xenopus
 
and mouse. This discrepancy is intriguing. However, even if
Figure 2. Constitutively active Rsk1 does not rescue the CSF arrest of
oocytes from the mos /  strain. (A) Time-lapse microscopy of maturing
oocytes from the Mos-deficient strain, either noninjected (white stars) or
injected with RNA-encoding Rsk1ca. Time points correspond to time after
meiosis resumption. Black dots show extrusion of the second polar body.
Gray dots correspond to the second polar body moving out of focus. Bar,
50  m. (B) Immunoblotting of 30 oocytes from the experiment shown in A,
either noninjected (NI) or injected with RNA-encoding Rsk1ca. Rsk1ca is
overexpressed about five times (top) after injection of the corresponding
RNA into oocytes from the mos /  strain. The top panel is revealed with
an anti-Rsk1 antibody. The bottom panel is revealed with an anti-ERK
antibody and serves as a loading control.
Figure 3. Constitutively active Rsk1 or 2 does not rescue the CSF arrest of
oocytes from the mos /  strain. (A–C) Phase-contrast images of oocytes
from the Mos-deficient strain, either noninjected (A), injected with RNA-
encoding Mos (B), or injected with Rsk2ca (C). Arrowheads point toward
the polar bodies (two in A and C, and one in B). Bar, 50  m. (D) Over-
expression of Mos, but not of Rsk1ca or Rsk2ca, rescues the MII arrest in
oocytes from mos /  mice, as evidenced by spontaneous second polar
body extrusion (%PB2). The number in parentheses corresponds to the number
of embryos analyzed. Error bars are the SD from three experiments. (E) Im-
munoblotting of 50 oocytes either noninjected (NI) or injected with RNA-
encoding Rsk1ca or Rsk2ca. Rsk1ca and Rsk2ca are overexpressed (bottom)
and active (top) after injection of the corresponding RNA into oocytes from
the wild-type or mos /  strain. The top panel is revealed with an anti-phos-
phoRsk antibody. The bottom panel is revealed with an anti-Flag antibody. 
JCB • VOLUME 169 • NUMBER 2 • 2005 230
 
the function of the CSF arrest is the same in these two verte-
brate species (i.e., preventing parthenogenetic activation), it
seems that the mechanisms at play are different. It has been
proposed that components of the spindle assembly checkpoint,
such as Mad1 and 2, are required for establishing CSF arrest in
 
Xenopus
 
 (Tunquist et al., 2003). Yet this is not the case in
mouse oocytes because the injection of dominant negative mu-
tants of BubR1 or Mad2 still allows the establishment of CSF
arrest (Tsurumi et al., 2004). We have recently identified sub-
strates of MAPK that are involved in stabilizing the MII spin-
dle of mouse oocytes, which suggests that the Mos–MAPK
pathway has essential targets, other than p90Rsk, on this struc-
ture (Lefebvre et al., 2002; Terret et al., 2003a). Mos has other
targets, apart from MEK, in mouse oocytes: it inhibits an oka-
daic acid–sensitive phosphatase, allowing MAPK activation to
occur (Verlhac et al., 2000). The observations made in mouse
oocytes show that the pathway leading to CSF arrest is not a
linear one, as it is in 
 
Xenopus
 
 (Gross et al., 2000). Eventually,
in mouse oocytes, cyclin B degradation is partially inhibited
during MII arrest and requires an intact spindle to be effective
(Kubiak et al., 1993). 
 
Xenopus
 
 oocytes are gigantic cells (1,000
times bigger than a mouse oocyte), whereas their MII spindles
are approximately the same size as those in mouse oocytes. The
difference between these two species may lie in the way the
two types of cells amplify a potential signal coming from a lo-
calized region of the cell; i.e., the spindle. Rsk1 and 2 are abun-
dant in 
 
Xenopus
 
 oocytes and embryos (Silverman et al., 2004).
We can then hypothesize that in this species, p90Rsk acts as an
amplifier of the Mos–MAPK signaling pathway in order to ac-
cumulate cyclin B, and hence stabilize maturation-promoting
factor activity. However, 
 
mos
 
 
 
/
 
 
 
 oocytes that are injected
with Rsk1ca extrude their second polar body with the same
timing as control, noninjected oocytes (Fig. 2); this strongly
suggests that, in mouse oocytes, cyclin B stability is not regu-
lated by p90Rsk activity. Therefore, our work and the work of
Tsurumi et al. (2004) show that many studies performed in the
 
Xenopus
 
 system are not relevant for mammals.
 
Materials and methods
 
Oocyte and embryo collection, culture, and microinjection
 
Wild-type oocytes and embryos were collected from 11-wk-old OF1 fe-
male mice. Oocytes were also collected from the Mos-deficient strain (Col-
ledge et al., 1994) or from the Rsk (1, 2, 3)–deficient strain. Mouse
oocytes and embryos were collected, cultured, and microinjected as
described previously (Verlhac et al., 2000), and mouse oocytes were pro-
cessed for immunofluorescence as described in Terret et al. (2003b). 
 
Xe-
nopus
 
 embryos were obtained from females injected with 500 IU of hu-
man chorionic gonadotropin (Sigma-Aldrich), were artificially fertilized,
and were processed as described previously (Carron et al., 2003). Micro-
injection of 2.5 ng of capped and purified RNA into one blastomere of a
two-cell 
 
Xenopus
 
 embryo was performed in 0.1
 
 
 
 MBS (modified Barth’s
solution) containing 3% Ficoll (Sigma-Aldrich), using a picoinjector (model
PLI-100; Medical Systems Corp.). After injection, embryos were main-
tained in the culture medium for 1 h and were further cultured in 0.1
 
 
 
MBS supplemented with 50 
 
 
 
g/ml gentamicin.
 
Imaging devices
 
Phase-contrast images of mouse oocytes and embryos were taken on an
inverted microscope (model DMIRBE; Leica; objective lenses 20
 
 
 
/PL fluo-
tar 0.5) equipped with a MicroMax camera (Roper Scientific) and driven
with the Metamorph software (Universal Imaging Corp.). The confocal im-
ages were taken on an inverted microscope (model TCSSP; Leica; objec-
tive lenses 40
 
 
 
/Plan Apo 0.75 and 63
 
 
 
/Plan Apo 1.32). Phase-contrast
images of 
 
Xenopus
 
 embryos were taken on a stereomicroscope (model
SZX9; Olympus) equipped with a camera (model DXC 950P; Sony).
 
In vitro transcription of synthetic RNA
 
The in vitro synthesis and purification of RNA was performed as described
in Terret et al. (2003b). The same RNA preparation was injected into
mouse oocytes and embryos, as well as into 
 
Xenopus
 
 embryos. The active
constructs of rat Rsk1 and mouse Rsk2 are described in Silverman et al.
(2004).
 
Immunoblotting
 
Immunoblotting of mouse oocytes and embryos was performed as de-
scribed previously (Verlhac et al., 2000). ERK1 and 2 were recognized us-
ing a specific anti-ERK antibody (sc-154; Santa Cruz Biotechnology, Inc.);
Rsk1 and 3 were recognized using antibodies sc-231 and sc-13379
(Santa Cruz Biotechnology, Inc.); and Rsk2 from mouse oocytes and em-
bryos was recognized using a specific antibody (sc-1430; Santa Cruz Bio-
technology, Inc.). Rsk2 from mitotic embryonic fibroblasts and liver extracts
was recognized with the antibody described in Zeniou et al. (2002). Active
Rsk was recognized using anti-phospho Rsk (sc-12445; Santa Cruz Bio-
technology, Inc.) directed against the PDK1 site present in Rsk1 and 2,
which enhances Rsk1 and 2 activity when phosphorylated. The Flag
epitope was recognized using an anti-Flag mAb (F3165; Sigma-Aldrich).
 
We thank James Maller (University of Colorado School of Medicine, Denver,
CO) for the gift of the constitutively active Rsk1 and 2. We thank
 
 
 
René Ozon
Figure 4. Oocytes from the Rsk (1, 2, 3)–deficient strain arrest in MII like
control oocytes. (A–C) Immunofluorescent images show the microtubules in
green and the chromosomes in red of control wild-type oocytes (A) and
oocytes from the Rsk (1, 2, 3)–deficient strain (B and C). Oocytes were
observed 19 h after GVBD ( 7 h in CSF arrest). (C) An MII spindle of an
oocyte from the Rsk (1, 2, 3)–deficient strain is observed under a 63 
objective to show the sister chromatids. Bar, 10  m. (D) Immunoblotting of
protein extracts from the mitotic embryonic fibroblasts of control mice (lane
1) or of Rsk (1, 2, 3)–deficient mice (lane 3), and of protein extracts from
the liver of control mice (lane 2) or of Rsk (1, 2, 3)–deficient mice (lane 4).
Extracts were probed using antibodies specific for Rsk1–3 and ERK1 and 2.
(E) Table showing the percentage of oocytes undergoing meiosis resump-
tion (GVBD) and MII arrest in control mice versus that in Rsk (1, 2, and 3)–
deficient mice. (F) Scheme of the pathway leading to CSF arrest in the
mouse oocyte, which does not go through p90Rsk to maintain a high
maturation-promoting factor activity. 
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